• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Rituximab, but not other antirheumatic therapies, is associated with impaired serological response to SARS- CoV-2 vaccination in patients with rheumatic diseases.

作者信息

Spiera Robert, Jinich Sarah, Jannat-Khah Deanna

机构信息

Department of Medicine, Division of Rheumatology, Hospital for Special Surgery, New York, New York, USA

Department of Medicine, Division of Rheumatology, Weill Cornell Medical College, New York, New York, USA.

出版信息

Ann Rheum Dis. 2021 Oct;80(10):1357-1359. doi: 10.1136/annrheumdis-2021-220604. Epub 2021 May 11.

DOI:10.1136/annrheumdis-2021-220604
PMID:33975857
Abstract
摘要

相似文献

1
Rituximab, but not other antirheumatic therapies, is associated with impaired serological response to SARS- CoV-2 vaccination in patients with rheumatic diseases.利妥昔单抗而非其他抗风湿疗法，与风湿性疾病患者对SARS-CoV-2疫苗的血清学反应受损有关。
Ann Rheum Dis. 2021 Oct;80(10):1357-1359. doi: 10.1136/annrheumdis-2021-220604. Epub 2021 May 11.
2
SARS-CoV-2 vaccination in rituximab-treated patients: evidence for impaired humoral but inducible cellular immune response.利妥昔单抗治疗患者的新型冠状病毒2型疫苗接种：体液免疫受损但细胞免疫反应可诱导的证据
Ann Rheum Dis. 2021 Oct;80(10):1355-1356. doi: 10.1136/annrheumdis-2021-220408. Epub 2021 May 6.
3
Correspondence on 'SARS-CoV-2 vaccination in rituximab-treated patients: evidence for impaired humoral but inducible cellular immune response'.关于“利妥昔单抗治疗患者的新型冠状病毒2疫苗接种：体液免疫受损但细胞免疫可诱导的证据”的通信
Ann Rheum Dis. 2021 Oct;80(10):e162. doi: 10.1136/annrheumdis-2021-220756. Epub 2021 Jul 16.
4
High antibody response to two-dose SARS-CoV-2 messenger RNA vaccination in patients with rheumatic and musculoskeletal diseases.风湿性和肌肉骨骼疾病患者对两剂严重急性呼吸综合征冠状病毒2信使核糖核酸疫苗的高抗体反应。
Ann Rheum Dis. 2021 Oct;80(10):1351-1352. doi: 10.1136/annrheumdis-2021-220656. Epub 2021 May 24.
5
SARS-CoV-2 vaccination in rituximab-treated patients: B cells promote humoral immune responses in the presence of T-cell-mediated immunity.在接受利妥昔单抗治疗的患者中接种 SARS-CoV-2 疫苗：B 细胞在 T 细胞介导的免疫存在下促进体液免疫反应。
Ann Rheum Dis. 2021 Oct;80(10):1345-1350. doi: 10.1136/annrheumdis-2021-220781. Epub 2021 Jul 20.
6
Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in adult patients with autoimmune inflammatory rheumatic diseases and in the general population: a multicentre study.BNT162b2 mRNA COVID-19 疫苗在成年自身免疫性炎症性风湿病患者和普通人群中的免疫原性和安全性：一项多中心研究。
Ann Rheum Dis. 2021 Oct;80(10):1330-1338. doi: 10.1136/annrheumdis-2021-220647. Epub 2021 Jun 14.
7
Impact of disease-modifying antirheumatic drugs on vaccine immunogenicity in patients with inflammatory rheumatic and musculoskeletal diseases.疾病修饰抗风湿药物对炎症性风湿和肌肉骨骼疾病患者疫苗免疫原性的影响。
Ann Rheum Dis. 2021 Oct;80(10):1255-1265. doi: 10.1136/annrheumdis-2021-221244. Epub 2021 Sep 7.
8
Successful BNT162b2 booster vaccinations in a patient with rheumatoid arthritis and initially negative antibody response.一名类风湿性关节炎患者接种BNT162b2加强针成功，且最初抗体反应呈阴性。
Ann Rheum Dis. 2021 Oct;80(10):1361-1362. doi: 10.1136/annrheumdis-2021-220834. Epub 2021 Jun 24.
9
Disease activity and humoral response in patients with inflammatory rheumatic diseases after two doses of the Pfizer mRNA vaccine against SARS-CoV-2.炎症性风湿病患者接种两剂辉瑞 SARS-CoV-2 mRNA 疫苗后的疾病活动和体液反应。
Ann Rheum Dis. 2021 Oct;80(10):1317-1321. doi: 10.1136/annrheumdis-2021-220503. Epub 2021 Jun 18.
10
Immunogenicity of SARS-CoV-2 vaccination in rituximab-treated patients: Effect of timing and immunologic parameters.利妥昔单抗治疗患者的 SARS-CoV-2 疫苗免疫原性：时机和免疫参数的影响。
Clin Immunol. 2022 Jan;234:108897. doi: 10.1016/j.clim.2021.108897. Epub 2021 Nov 27.

引用本文的文献

1
The T-cell response to SARS-CoV- 2 vaccination persists beyond six months in rheumatoid arthritis patients treated with rituximab.在用利妥昔单抗治疗的类风湿性关节炎患者中，T细胞对SARS-CoV-2疫苗接种的反应持续超过六个月。
Arthritis Res Ther. 2025 Apr 16;27(1):86. doi: 10.1186/s13075-025-03553-4.
2
The Expanding Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Armamentarium.不断扩展的抗中性粒细胞胞浆抗体相关性血管炎治疗手段
Drugs. 2025 Mar;85(3):325-341. doi: 10.1007/s40265-024-02143-z. Epub 2025 Feb 19.
3
Adaptive clinical trial of AZD7442 and SARS-CoV-2 vaccination in immunosuppressed patients highly vulnerable to infection with SARS-CoV-2 virus (RAPID-PROTECTION): protocol for a multicentre, interventional open-label, randomised controlled trial.
AZD7442与SARS-CoV-2疫苗在极易感染SARS-CoV-2病毒的免疫抑制患者中的适应性临床试验（快速保护）：一项多中心、介入性开放标签、随机对照试验方案
BMJ Open. 2025 Jan 20;15(1):e084345. doi: 10.1136/bmjopen-2024-084345.
4
4th booster-dose SARS-CoV-2 heterologous and homologous vaccination in rheumatological patients.风湿免疫病患者接种第 4 剂 SARS-CoV-2 异源和同源加强疫苗。
Front Immunol. 2024 Jul 26;15:1427501. doi: 10.3389/fimmu.2024.1427501. eCollection 2024.
5
Harnessing immunity: Immunomodulatory therapies in COVID-19.利用免疫：COVID-19中的免疫调节疗法。
World J Virol. 2024 Jun 25;13(2):92521. doi: 10.5501/wjv.v13.i2.92521.
6
Factors associated with immune responses to SARS-CoV-2 vaccination in individuals with autoimmune diseases.与自身免疫性疾病患者对 SARS-CoV-2 疫苗免疫反应相关的因素。
JCI Insight. 2024 Jun 4;9(13):e180750. doi: 10.1172/jci.insight.180750.
7
COVID-19 Vaccine Effectiveness among Patients with Psoriatic Disease: A Population-Based Study.银屑病患者中COVID-19疫苗的有效性：一项基于人群的研究。
Vaccines (Basel). 2024 Apr 24;12(5):453. doi: 10.3390/vaccines12050453.
8
Effect of Immunosuppression on the Immune Response to SARS-CoV-2 Infection and Vaccination.免疫抑制对 SARS-CoV-2 感染和疫苗接种免疫反应的影响。
Int J Mol Sci. 2024 May 11;25(10):5239. doi: 10.3390/ijms25105239.
9
Understanding patient perspectives on vaccine decision making in adults with autoimmune bullous diseases: a qualitative study.理解成人自身免疫性大疱性疾病患者对疫苗决策的看法：一项定性研究。
Arch Dermatol Res. 2024 Apr 18;316(5):125. doi: 10.1007/s00403-024-02862-z.
10
Public Perception of SARS-CoV-2 Vaccines Among Psoriasis Patients in Social Media: Content, Sentiment, and Engagement Analysis.社交媒体中银屑病患者对SARS-CoV-2疫苗的公众认知：内容、情感及参与度分析
J Psoriasis Psoriatic Arthritis. 2022 Oct;7(4):164-173. doi: 10.1177/24755303221110095.